Janson Trieu’s path to oncology was deeply personal. After losing a close friend to cancer at a young age, he decided to turn personal loss into a career focused on treatment, research and patient care.
At Comprehensive Cancer Centers of Nevada, Trieu specializes in genitourinary and skin cancers and serves as principal investigator on the Merck KEYVIBE010 Phase 3 melanoma trial. He is also a sub-investigator on five active studies involving prostate, lung and hematologic cancers, helping bring national clinical trials to local patients and expand access to more personalized therapies close to home.
Trieu also presents cancer education at community events such as the Aging Wellness Expo and mentors early-career clinicians. At UNLV, he co-founded the Hematology and Oncology Interest Group, helping connect medical students and residents to research, mentorship and clinical opportunities in Southern Nevada.